Can damaged cartilage truly heal, or does the body settle for a weaker substitute? The medical community has spent decades researching why cartilage struggles to repair itself, what fibrocartilage really means for long-term joint health, and how modern cellular therapies may reduce pain, slow degeneration, and delay surgery. A deeper understanding of cartilage biology allows treatment to shift from temporary symptom relief to long-term joint protection.
Why Cartilage has Limited Healing Potential
Unlike bone or muscle, cartilage has a very limited capacity for self-repair. It lacks its own blood supply, nerves, and lymphatic drainage. As a result, damaged cartilage receives fewer nutrients and repair cells, making natural regeneration extremely difficult. Once cartilage begins to deteriorate, the process often progresses over time rather than reversing on its own.
Small cartilage defects may remain stable for years, but true restoration of normal, durable cartilage rarely occurs without intervention.
What the Body does after Cartilage Injury
Following cartilage damage, the body may produce fibrocartilage as a repair response. While fibrocartilage can reduce symptoms temporarily, it is structurally inferior to native hyaline cartilage. It lacks the same strength, elasticity, and wear resistance, which means it is more likely to break down over time and contribute to ongoing joint degeneration.
These limitations have led to growing interest in biologic and cellular therapies designed to support joint health and slow disease progression.
What Cellular Therapies Can Do
Cellular therapies, including platelet-rich plasma (PRP), bone marrow–derived cell concentrates, and other biologic treatments, are not capable of fully regenerating lost cartilage. However, they can play an important role in managing joint conditions.
These therapies may help by:
- Reducing joint inflammation
- Improving the biologic environment within the joint
- Supporting the body’s natural repair processes
- Slowing cartilage degeneration
- Reducing pain and improving function
For appropriately selected patients, particularly those with early to moderate cartilage damage, cellular therapies may help preserve existing cartilage and delay the need for more invasive procedures.
What Cellular Therapies Cannot Do
It is equally important to understand their limitations. Cellular therapies:
- Cannot regenerate large areas of missing cartilage
- Cannot reverse advanced “bone-on-bone” arthritis
- Cannot correct significant joint deformity or malalignment
- Are not a replacement for surgery in advanced disease
Claims of complete cartilage regrowth should be approached with caution. Treatment outcomes vary based on the extent of cartilage loss, patient age, joint mechanics, activity level, and overall health.
How Cellular Therapies Fit into Comprehensive Care
At the American Hip Institute, cellular therapies are viewed as one component of a comprehensive, evidence-based treatment strategy. They may complement physical therapy, activity modification, weight management, and surgical cartilage restoration procedures when appropriate. In advanced cases, surgical intervention, including joint preservation or replacement, may offer the most reliable long-term solution.
Frequently Asked Questions About Cellular Therapies and Cartilage Health
Can damaged hip cartilage heal on its own?
Cartilage has very limited healing ability because it lacks a direct blood supply and repair cells. While small defects may remain stable for a time, true regeneration of durable, healthy cartilage is uncommon without medical intervention.
What is fibrocartilage, and why isn’t it as strong as normal cartilage?
Fibrocartilage is the body’s natural repair tissue after cartilage injury. Although it may temporarily reduce pain, it is less elastic and more prone to wear than native hyaline cartilage, which can contribute to ongoing degeneration over time.
Who may benefit most from cellular therapies?
Patients with early to moderate cartilage damage, inflammation-related symptoms, or mild degenerative changes often see the greatest benefit. Proper patient selection based on imaging, joint mechanics, and overall health is essential for meaningful results.
Do cellular therapies regrow cartilage completely?
No. Current biologic and cellular treatments cannot fully regenerate large areas of lost cartilage or reverse advanced arthritis. Their primary role is to support the joint environment, reduce inflammation, and potentially slow the progression of degeneration.
Can cellular therapies delay hip replacement surgery?
In some cases, yes. When used appropriately in earlier stages of disease, these treatments may help manage symptoms and preserve joint function, potentially postponing the need for more invasive surgical procedures.
How do cellular therapies fit into long-term hip care?
They are typically one part of a broader treatment plan that may include physical therapy, lifestyle modification, joint preservation surgery, or replacement when necessary. At the American Hip Institute, cellular therapies are integrated into comprehensive, evidence-based strategies designed to protect joint health and support lasting function rather than provide short-term symptom relief alone.
Hear From Our Patients
Choosing the right orthopedic care is a deeply personal decision, especially when considering treatments designed to preserve cartilage and delay more invasive surgery. Patients who have pursued comprehensive, evidence-based care often describe meaningful improvements in comfort, mobility, and confidence in their long-term joint health. To learn more about the personalized, patient-centered approach to cartilage preservation and biologic treatment strategies, explore patient experiences at the American Hip Institute.
AUTHOR: Mark F. Schinsky, MD, FAAOS, CIME – Orthopedic Hip & Knee Replacement Surgeon
Mark F. Schinsky, M.D., FAAOS, CIME is a fellowship-trained, board-certified orthopedic surgeon specializing in adult reconstructive orthopaedic surgery, hip replacement, knee replacement, and regenerative medicine. He serves as Director of Complex Hip & Knee Replacement and is recognized for advanced expertise in minimally invasive, complex primary, and revision total joint replacement procedures.
Credentials & Recognition
Dr. Schinsky earned his medical degree from the Columbia University College of Physicians & Surgeons and completed elite orthopaedic training at Barnes-Jewish Hospital affiliated with Washington University in St. Louis, as well as RUSH University.
With extensive clinical experience and thousands of successful hip and knee replacements performed, Dr. Schinsky is widely respected for his precision, surgical judgment, and commitment to improving patient mobility and quality of life. He has also contributed to the design of innovative orthopaedic implants and regularly travels nationally and internationally to educate surgeons on the latest joint replacement technologies and surgical techniques.
Clinical Expertise
Dr. Schinsky focuses on minimally invasive joint replacement, complex primary and revision hip and knee arthroplasty, and advanced reconstructive procedures tailored to each patient’s anatomy and functional goals. He treats patients from the Chicagoland region and across the country who seek specialized expertise in complex joint reconstruction. His patient-centered approach emphasizes individualized care, modern surgical technology, and comprehensive recovery planning to restore long-term function and independence.
Medical Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. For diagnosis and treatment recommendations, please consult with Dr. Schinsky or another qualified orthopedic specialist at the American Hip Institute.
Content authored by Dr. Schinsky and verified against official sources.
Reference Links: